Skip to content

Clinical trials

Phase 2 Prostatic Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 2 Country / region: Taiwan Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20142
20162
20171
20191
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.2
Janssen Research & Development, LLC2
Bayer1
Chang Gung Memorial Hospital1
Daiichi Sankyo1
Exelixis1
Health Ever Bio-Tech Co., Ltd.1
Novartis Pharmaceuticals1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms11
Carcinoma, Non-Small-Cell Lung3
Melanoma3
Breast Neoplasms2
Ovarian Neoplasms2
Pancreatic Neoplasms2
Small Cell Lung Carcinoma2
Carcinoma, Hepatocellular1
Endometrial Neoplasms1
Esophageal Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.